Sarcopenic osteoporosis, sarcopenic obesity, and sarcopenic osteoporotic obesity in the Camargo cohort (Cantabria, Spain)
- Standort
-
Deutsche Nationalbibliothek Frankfurt am Main
- ISSN
-
1862-3514
- Umfang
-
Online-Ressource
- Sprache
-
Englisch
- Anmerkungen
-
online resource.
- Erschienen in
-
Sarcopenic osteoporosis, sarcopenic obesity, and sarcopenic osteoporotic obesity in the Camargo cohort (Cantabria, Spain) ; volume:17 ; number:1 ; day:29 ; month:7 ; year:2022 ; pages:1-10 ; date:12.2022
Archives of osteoporosis ; 17, Heft 1 (29.7.2022), 1-10, 12.2022
- Urheber
-
Hernández-Martínez, Paula
Olmos, José M.
Llorca, Javier
Hernández, José L.
González-Macías, Jesús
- Beteiligte Personen und Organisationen
-
SpringerLink (Online service)
- DOI
-
10.1007/s11657-022-01146-1
- URN
-
urn:nbn:de:101:1-2022101518360222029832
- Rechteinformation
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Letzte Aktualisierung
-
15.08.2025, 07:22 MESZ
Datenpartner
Dieses Objekt wird bereitgestellt von:
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Beteiligte
- Hernández-Martínez, Paula
- Olmos, José M.
- Llorca, Javier
- Hernández, José L.
- González-Macías, Jesús
- SpringerLink (Online service)
Ähnliche Objekte (12)
Obesity as a premature aging phenotype — implications for sarcopenic obesity
Impact of whole body electromyostimulation on cardiometabolic risk factors in older women with sarcopenic obesity: the randomized controlled FORMOsA-sarcopenic obesity study
Impact of whole body electromyostimulation on cardiometabolic risk factors in older women with sarcopenic obesity: the randomized controlled FORMOsA sarcopenic obesity study
Impact of whole body electromyostimulation on cardiometabolic risk factors in older women with sarcopenic obesity: the randomized controlled FORMOsA-sarcopenic obesity study
Sarcopenic Obesity and Cardiovascular Disease: An Overlooked but High-Risk Syndrome
Myostatin as a plausible biomarker for early stage of sarcopenic obesity
Sex Differences in Bone Health Among Indian Older Adults with Obesity, Sarcopenia, and Sarcopenic Obesity
Prevalence and associations of sarcopenia, obesity and sarcopenic obesity in end-stage knee osteoarthritis patients
The effect of sarcopenia and sarcopenic obesity on survival in gastric cancer
Decreased intracellular water is associated with sarcopenic obesity in chronic haemodialysis patients
Definition and Diagnostic Criteria for Sarcopenic Obesity: ESPEN and EASO Consensus Statement
Functional body composition : implications for cardiometabolic risk and the diagnosis of sarcopenic obesity
Obesity as a premature aging phenotype — implications for sarcopenic obesity
Impact of whole body electromyostimulation on cardiometabolic risk factors in older women with sarcopenic obesity: the randomized controlled FORMOsA-sarcopenic obesity study
Impact of whole body electromyostimulation on cardiometabolic risk factors in older women with sarcopenic obesity: the randomized controlled FORMOsA sarcopenic obesity study
Impact of whole body electromyostimulation on cardiometabolic risk factors in older women with sarcopenic obesity: the randomized controlled FORMOsA-sarcopenic obesity study
Sarcopenic Obesity and Cardiovascular Disease: An Overlooked but High-Risk Syndrome
Myostatin as a plausible biomarker for early stage of sarcopenic obesity
Sex Differences in Bone Health Among Indian Older Adults with Obesity, Sarcopenia, and Sarcopenic Obesity
Prevalence and associations of sarcopenia, obesity and sarcopenic obesity in end-stage knee osteoarthritis patients
The effect of sarcopenia and sarcopenic obesity on survival in gastric cancer
Decreased intracellular water is associated with sarcopenic obesity in chronic haemodialysis patients
Definition and Diagnostic Criteria for Sarcopenic Obesity: ESPEN and EASO Consensus Statement
Functional body composition : implications for cardiometabolic risk and the diagnosis of sarcopenic obesity
Obesity as a premature aging phenotype — implications for sarcopenic obesity
Impact of whole body electromyostimulation on cardiometabolic risk factors in older women with sarcopenic obesity: the randomized controlled FORMOsA-sarcopenic obesity study
Impact of whole body electromyostimulation on cardiometabolic risk factors in older women with sarcopenic obesity: the randomized controlled FORMOsA sarcopenic obesity study
Impact of whole body electromyostimulation on cardiometabolic risk factors in older women with sarcopenic obesity: the randomized controlled FORMOsA-sarcopenic obesity study
Sarcopenic Obesity and Cardiovascular Disease: An Overlooked but High-Risk Syndrome
Myostatin as a plausible biomarker for early stage of sarcopenic obesity
Sex Differences in Bone Health Among Indian Older Adults with Obesity, Sarcopenia, and Sarcopenic Obesity
Prevalence and associations of sarcopenia, obesity and sarcopenic obesity in end-stage knee osteoarthritis patients
The effect of sarcopenia and sarcopenic obesity on survival in gastric cancer
Decreased intracellular water is associated with sarcopenic obesity in chronic haemodialysis patients
Definition and Diagnostic Criteria for Sarcopenic Obesity: ESPEN and EASO Consensus Statement